$ARAY News

Last published 6d ago

6d agoARAYTrading halt: Accuray Incorporated (ARAY), News pendingNasdaq Trading HaltsHalted 2026-11-06 19:50:00.000 ET, resumption quote none, resumption trade none.
1w agoARAYACCURAY INC - EXHIBIT 99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 7.01 Item 9.01
1w agoARAYAccuray Incorporated Reports Inducement Award Under NASDAQ Listing RulesPR NewswireMADISON, Wis., Oct. 30, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ:ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Sofiane Laoussadi, the company's new Senior Vice
3w agoARAYAccuray to Report First Quarter Fiscal 2027 Financial Results on November 4, 2026PR NewswireMADISON, Wis., Oct. 21, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ:ARAY) will report financial results for the first quarter of fiscal year 2027, ended September 30, 2026, during a conference call hosted by
1mo agoARAYAccuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent DirectorPR NewswireAccuray Incorporated (Nasdaq: ARAY) today announced that stockholders approved all proposals presented at the company's Special Meeting of...
1mo agoARAYAccuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® PlatformPR NewswireAccuray Incorporated (NASDAQ: ARAY) today announced that it had entered into agreements with Samsung HME America, Inc., dba NeuroLogica Corp....
2mo agoARAYAccuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive CapabilitiesPR NewswireAccuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems for cancer treatment, and RaySearch Laboratories AB (publ) today ...
2mo agoARAYAccuray Reports Fourth Quarter and Fiscal 2026 Financial ResultsPR NewswireAccuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2026, ended June 30, 2026. Key Highlights The...
3mo agoARAYAccuray Advances Strategic Priorities Through Key Executive Leadership AppointmentsPR NewswireMADISON, Wis., Aug. 12, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ:ARAY) announced two key leadership appointments intended to improve operational execution and profitability, deliver increased customer value,
3mo agoARAYAccuray to Report Fourth Quarter Fiscal 2026 Financial Results on August 19, 2026PR NewswireAccuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter of fiscal year 2026, ended June 30, 2026, during a...
3mo agoARAYAccuray Announces Plan Involving Financial Strengthening, Strategic Partnerships, Technology Rollouts, and Operational Initiatives to Drive Long-Term Value CreationPR NewswireAccuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems for cancer treatment, today announced a plan incorporating...
5mo agoARAYAccuray Incorporated Reports Inducement Award Under NASDAQ Listing RulesPR NewswireAccuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Paul Miele, the company's new...
6mo agoARAYAccuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with CancerPR NewswireAccuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced a new 10‑year strategic...
6mo agoARAYAccuray Reports Fiscal 2026 Third Quarter Financial ResultsPR NewswireAccuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter ended March 31, 2026. Key Highlights Transformation plan...
6mo agoARAYAccuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026PR NewswireAccuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a...
7mo agoARAYAccuray Appoints Paul Miele as Senior Vice President and Chief Commercial OfficerPR NewswireAccuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems for cancer treatment, today announced the appointment of Paul...
9mo agoARAYAccuray Reports Fiscal 2026 Second Quarter Financial ResultsPR NewswireAccuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter ended December 31, 2025. Key Highlights On December 15,...
9mo agoARAYAccuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026PR NewswireAccuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2026, ended December 31, 2025, during a...
11mo agoARAYAccuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growthPR NewswireAccuray Incorporated (NASDAQ: ARAY) today announced the first phase of its comprehensive strategic, operational, and organizational transformation...
1y agoARAYAccuray Reports Fiscal 2026 First Quarter Financial ResultsPR NewswireAccuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter ended September 30, 2025. Key Highlights On October 20,...
1y agoARAYAccuray Incorporated Reports Inducement Award Under NASDAQ Listing RulesPR NewswireAccuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Stephen La Neve, the company's...
1y agoARAYAccuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025PR NewswireAccuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2026, ended September 30, 2025, during a...
1y agoARAYAccuray Accelerates Transformation Efforts with Appointment of Experienced Executive Leaders to Drive Performance and GrowthPR NewswireAccuray Incorporated (NASDAQ: ARAY) today announced it is engaging in a significant organizational, strategic, and operational transformation. To...
1y agoARAYAccuray Announces Milestone for Cancer Patients in Melbourne, Australia with First SBRT Treatments Using the CyberKnife® SystemPR NewswireAccuray Incorporated (NASDAQ: ARAY) announced today that 5D Clinics has treated the first patients in the city of Melbourne, Australia, using the...
1y agoARAYAccuray and the University of Wisconsin-Madison Announce Memorandum of Understanding to Advance Online Adaptive Radiotherapy in Support of Improving Cancer Patient CarePR NewswireAccuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced today the signing of a...
1y agoARAYAccuray Launches All-in-One Radiotherapy Solution With Advanced Capabilities Designed to Set a New Standard in Cancer CarePR NewswireAccuray Incorporated (NASDAQ: ARAY) announced today that the company is advancing its legacy of leadership in adaptive radiotherapy with the...
1y agoARAYAccuray to Host Analyst Event at the American Society of Radiation Oncology Meeting on September 29, 2025PR NewswireAccuray Incorporated (NASDAQ: ARAY) announced today that the company will host a discussion with analysts and investors on Monday, September 29,...
1y agoARAYAccuray Incorporated (ARAY) Q4 2025 Earnings Call TranscriptEarnings Call Transcripts
1y agoARAYAccuray Reports Fourth Quarter and Fiscal 2025 Financial ResultsPR NewswireAccuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2025, ended June 30, 2025. Key Fiscal Fourth...
1y agoARAYAccuray to Report Fourth Quarter Fiscal 2025 Financial Results on August 13, 2025PR NewswireAccuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter of fiscal year 2025, ended June 30, 2025, during a...
1y agoONCY CLRB INTS ARAY+1Oncology Innovation Just Hit a Turning Point -- Here's What to WatchPR NewswireUSA News Group News Commentary – The oncology landscape is being pulled in two directions. On one hand, U.S. cancer death rates continue to decline....
1y agoARAYAccuray Announces Convertible Notes Exchange and Refinancing of Existing Credit FacilitiesPR NewswireAccuray Incorporated (NASDAQ: ARAY) today announced that, after an extensive review over the last several months, including the evaluation of...
1y agoARAYAccuray to Participate in the Jefferies Global Healthcare Conference 2025PR NewswireAccuray Incorporated (NASDAQ: ARAY) announced today its participation in the Jefferies Global Healthcare Conference 2025. The management team is...
1y agoARAYAccuray Showcases New Long-Term Data¹ on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025PR NewswireAccuray Incorporated (NASDAQ: ARAY) announced today that new data presented at the European Society for Radiotherapy and Oncology (ESTRO) meeting...
1y agoARAYAccuray Announces First SRS/SBRT Patient Treatments in Austria With the CyberKnife® SystemPR NewswireAccuray Incorporated (NASDAQ: ARAY) announced today that the CyberKnife® Center Salzburg is the first in Austria to treat patients with the...
1y agoARAYAccuray Reports Fiscal 2025 Third Quarter Financial ResultsPR NewswireAccuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter ended March 31, 2025. Key Fiscal Third Quarter Highlights: ...
1y agoARAYAccuray to Report Third Quarter Fiscal 2025 Financial Results on April 30, 2025PR NewswireAccuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2025, ended March 31, 2025, during a...
1y agoARAYAccuray CyberKnife® Platform Featured in New Studies Showcasing its Benefits in Central Nervous System Tumors Presented at Radiosurgery Society Scientific MeetingPR NewswireAccuray Incorporated (NASDAQ: ARAY) announced today that new data on the clinical use of the CyberKnife® System reinforce the device's broad-based...
1y agoARAYAccuray to Participate at 37th Annual Roth ConferencePR NewswireAccuray Incorporated (NASDAQ: ARAY) today announced its participation in the 37th Annual Roth Conference taking place on March 16 -18, 2025 in Dana...
1y agoARAYAccuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises GuidancePR NewswireAccuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter ended December 31, 2024. Key Fiscal Q2 Highlights: Strong ...
1y agoARAYAccuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture ProductPR NewswireAccuray Incorporated (NASDAQ: ARAY) announced today that Shandong Cancer Hospital and Institute has achieved a milestone with the completion of...
1y agoARAYAccuray to Report Second Quarter Fiscal 2025 Financial Results on February 5, 2025PR NewswireAccuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2025, ended December 31, 2024, during a...
1y agoARAYLeonel Peralta to Join Accuray as Chief Operations OfficerPR NewswireAccuray Incorporated (NASDAQ: ARAY) announced today that Leonel Peralta is joining the company as Senior Vice President, Chief Operations Officer,...
1y agoARAYAccuray Announces China National Medical Products Administration Approval of the Radixact® SynC™ and CyberKnife® S7™ Systems; Expands on the China Product Portfolio that Includes the Recently Approved Tomo® C SystemPR NewswireAccuray Incorporated (NASDAQ: ARAY) announced today that the company's Radixact SynC™ System and CyberKnife® S7™ System have been approved by the...
1y agoARAYNew Data Indicates the CyberKnife® System Can Provide a Safe and Effective Treatment Option to Control Brainstem Metastases, an Extremely Challenging Location to TreatPR NewswireAccuray Incorporated (NASDAQ: ARAY) announced today an international retrospective multicenter analysis found that radiosurgery (SRS) and...
1y agoARAYAccuray Incorporated Reports Inducement Award Under NASDAQ Listing RulesPR NewswireAccuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Mike Murphy, the company's new...
2y agoARAYAccuray Incorporated (ARAY) Q1 2025 Earnings Call TranscriptEarnings Call Transcripts
2y agoARAYAccuray Reports Fiscal 2025 First Quarter Financial ResultsPR NewswireAccuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter ended September 30, 2024. "We continue to make solid...
2y agoARAYAccuray to Report First Quarter Fiscal 2025 Financial Results on November 6, 2024PR NewswireAccuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2025, ended September 30, 2024, during a...
2y agoARAYAccuray Appoints Michael Murphy as VP, Corporate ControllerPR NewswireAccuray Incorporated (NASDAQ: ARAY) announced today that Michael Murphy, CPA has joined the company as Vice President, Corporate Controller. Mr....